This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (16)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

An Experiment in the Use of D-Lysergic Acid Diethylamide (LSD-25)

ALFRED M. FREEDMAN, M.D.; EVA V. EBIN, M.D.; ETHEL A. WILSON

Arch Gen Psychiatry. 1962;6(3):203-213.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Introduction

Since the hallucinogenic properties of Dlysergic acid diethylamide (LSD-25) were accidentally discovered by Hoffman in 1943 there has been wide experimentation with the drug designed to test its properties both as a psychotomimetic and as a therapeutic agent. It has been considered by some investigators as having great value in revealing the nature of the schizophrenic state and thereby advancing the understanding that leads to progress in therapy. However, other investigators, while acknowledging the undoubted psychic effects of the drug, insist that the LSD experience cannot be equated with naturally occurring psychosis.¹ It is not the first psychopharmaceutical agent to be used as an adjunct to psychotherapy; most of its predecessors were greeted with equal enthusiasm by some because of their action in unlocking the gates of repression and thus leading to disinhibition and catharsis. In fact, according to Hoch,² careful studies . . . [Full Text PDF of this Article]

Author Affiliations
NEW YORK

Department of Psychiatry, New York Medical College.

Present Address: Creedmoor State Hospital, New York City (Dr. Ebin).

Footnotes
Submitted for publication July 6, 1961.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?